• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Public Workshop: Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors

The Food and Drug Administration (FDA) is announcing a public workshop entitled “Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors” to initiate dialogue and share information about the design of drug and therapeutic biologic container labels, carton labeling, and product packaging, and practices to develop testing of proprietary names to reduce medication errors.  The input from this workshop will be used to develop draft guidance for industry in these areas to reduce medication errors.  A public docket [FDA-2010-N-0168-0001] is open until July 23, 2010 to receive comments on this topic.

Date and Time:  The meeting is two days. Thursday, June 24, 2010 from 8:30am – 4:00pm and Friday, June 25, 2010 from 8:30am – Noon. 

New Location: Holiday Inn College Park, 10000 Baltimore Ave., College Park, MD 20740, 301-345-6700, www.holidayinncollegepark.comExit Disclaimer

Contact Person:  Colleen O’Malley, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 4305, Silver Spring, MD 20993, 301-796-1786, FAX 301-796-9832, e-mail: colleen.omalley@fda.hhs.gov

Registration and Requests for Oral Presentations: The registration deadline to make an oral presentation was May 25, 2010 and is now closed.

The public is welcome to attend the workshop on a first-come, first served basis.

If you need special accommodations due to a disability, please contact Colleen O’Malley at least seven days in advance.